| Literature DB >> 28723122 |
Sahar S Mahshid1,2, Francesco Ricci3, Shana O Kelley2, Alexis Vallée-Bélisle1.
Abstract
The development of a universal sensing mechanism for the rapid and quantitative detection of small molecules directly in whole blood would drastically impact global health by enabling disease diagnostics, monitoring, and treatment at home. We have previously shown that hybridization between a free DNA strand and its complementary surface-bound strand can be sterically hindered when the former is bound to large antibodies. Here, we exploit this effect to design a competitive antibody-based electrochemical assay, called CeSHHA, that enables the quantitative detection of small molecules directly in complex matrices, such as whole blood or soil. We discuss the importance of this inexpensive assay for point-of-care diagnosis and for treatment monitoring applications.Keywords: DNA nanotechnology; biosensors; point-of-care; therapeutic drug monitoring; whole blood
Year: 2017 PMID: 28723122 DOI: 10.1021/acssensors.7b00176
Source DB: PubMed Journal: ACS Sens ISSN: 2379-3694 Impact factor: 7.711